SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CSPC Group Starts Phase II Trial of New Hypertension Drug

CSPC Group has started a Phase II clinical trial for a new hypertension drug.

Related stories